Teva Pharmaceuticals
TEVA
TEVA
425 hedge funds and large institutions have $3.73B invested in Teva Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 130 increasing their positions, 137 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
6.24% less ownership
Funds ownership: 50.4% → 44.16% (-6.2%)
17% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 60
25% less capital invested
Capital invested by funds: $4.94B → $3.73B (-$1.21B)
Holders
425
Holding in Top 10
13
Calls
$162M
Puts
$145M
Top Buyers
| 1 | +$107M | |
| 2 | +$96.2M | |
| 3 | +$93.7M | |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$87.1M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$59M |
Top Sellers
| 1 | -$731M | |
| 2 | -$382M | |
| 3 | -$177M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$38.1M |
| 5 |
Citigroup
New York
|
-$30.6M |